Compare MPTI & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPTI | PMVP |
|---|---|---|
| Founded | 1965 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.9M | 66.0M |
| IPO Year | N/A | 2020 |
| Metric | MPTI | PMVP |
|---|---|---|
| Price | $57.48 | $1.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 37.7K | ★ 231.9K |
| Earning Date | 02-25-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.64 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $52,989,000.00 | N/A |
| Revenue This Year | $13.32 | N/A |
| Revenue Next Year | $10.56 | N/A |
| P/E Ratio | $24.27 | ★ N/A |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $34.50 | $0.81 |
| 52 Week High | $61.91 | $1.84 |
| Indicator | MPTI | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 65.19 | 45.61 |
| Support Level | $51.45 | $1.20 |
| Resistance Level | $58.77 | $1.27 |
| Average True Range (ATR) | 2.44 | 0.06 |
| MACD | 0.62 | 0.01 |
| Stochastic Oscillator | 93.63 | 61.11 |
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.